Neoss® Group Opens Two New Sales Offices in Europe

Neoss® Group has announced the opening of two new sales organizations, Neoss Norden AB and Neoss UK & Ireland Ltd. These two organizations will ensure our continued growth and commercialization of our expanding product portfolio in the region. Most important, it will help us to better support dental professionals and their patients in Europe. Both organizations will begin operations December 1st, 2022.

“These two organizations are an important foundation to be able to support our growing customer base in Europe. Increasing our footprint in these markets is important to us, this is where it all started for Neoss. The Nordic region is particularly important due to it is where our implants are produced, our R&D is located and the dental implant heritage.”

Dr. Robert Gottlander, President and CEO of Neoss Group

As previously announced, Albin Wahlstrand will be the Managing Director for Neoss Norden AB. He brings over 20 years of experience within the dental industry and has worked with every aspect of the dental business including sales, product management, and business development.

Neoss Norden AB organization is located in the Biotech Center building next to the Institute of Odontology, University of Gothenburg. Neoss Norden AB, Arvid Wallgrens backe 20, 413 46 Göteborg, Sweden.

Fernando Spieler, current National Sales Manager will be promoted to Managing Director for the newly formed Neoss UK & Ireland Ltd. He has been part of the Neoss family for almost 2 years and before this has over 15 years of experience within the medical device industry.

Neoss UK & Ireland Ltd organization is in the same building as Neoss Ltd, Windsor House, Cornwall Rd, Harrogate HG1 2PW, United Kingdom.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”